This July 2021 peer-reviewed study investigates the use of chlorine dioxide (ClO2) for treatment of COVID-19 disease, AIDS and Influenza in humans. Interesting findings include that, at low concentrations, ClO2⁻ can protect erythrocytes from oxidative stress while at the same time inhibiting the excessive production of hypochlorous acid (HClO) induced by myeloperoxidase (MPO), thus reversing inflammatory responses and macrophage activation, protects cells from death caused by hydrogen peroxide (H2O2), improves the expression and activities of antioxidant enzymes, such as superoxide dismutase, catalase and glutathione peroxidase, and contributes to the resolution of the inflammatory process.
